from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1633/uvrB

LFCtreatmentdescriptionclass of inhibitor

-0.884

Amikacinug/mL Amikacintranslation

-1.358

Cap5-10ug/mL Capreomycintranslation

-2.766

Rox10-50 ug/mL Roxithromycintranslation

-0.708

SM2-5 ug/mL Streptomycintranslation

-0.377

Tet5-10 ug/mL Tetracyclinetranslation

-0.955

Rif0.2-5ug/mL Rifampicintranscription

0.040

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.063

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.953

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.293

CPZ10-50 ug/mL Chlorpromazinerespiration

0.335

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.414

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.658

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.610

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.099

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.185

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.414

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.571

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.020

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.716

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.055

KCN5-20 ug/mL Potassium cyaniderespiration

-0.105

NaN30.2-2 mM Sodium aziderespiration

0.629

Nigericin50 uM Nigericinrespiration

0.784

TRC10-150 ug/mL Triclosanrespiration

0.842

TRZ10-25 ug/mL Thioridazinerespiration

-0.728

Valinomycin0.5-10 uM Valinomycinrespiration

-0.537

ZnSO42 mM ZnSO4respiration

0.650

menadione6-10 ug/mL Menadionerespiration

-0.051

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.566

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.490

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.167

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.358

NRP_1Non-replicating persistence stage 1dosRassociated

-0.592

Amp0.2mg/mL AmpicillincellWall

-0.295

Cephalexin20-100 ug/mL CephalexincellWall

-0.314

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.059

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.262

EMB10-20 ug/mL EthambutolcellWall

-0.092

Eta12-40 ug/mL EthionamidecellWall

-0.045

INH0.2-0.4 ug/mL IsoniazidcellWall

0.165

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.482

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.660

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.646

BZA0.12 mg/mL BenzamidearomaticAmides

-0.074

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.108

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.152

H2O24 mM hydrogen peroxideDNAdamaging

1.277

Levo10 ug/mL LevofloxacinDNAdamaging

0.588

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.315

Novobiocin10 ug/mL NovobiocinDNAdamaging

2.149

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.044

UVUV-irradiationDNAdamaging

-1.802

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.589

Antimycin12.5-50 ug/mL Antimycin A?

-0.674

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.196

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.210

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.117

PA8240.2-2 ug/mL PA-824?

0.193

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.507

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.481

Verapamil50 uM Verapamil?

-0.037

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.780

methoxatin10-20 ug/mL Methoxatin?